MedTrace Logo

Long-term Effects of Highly Active Anti-Retroviral Therapy on HIV-Infected Children

NCT00260806 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2014-03-18

No results posted yet for this study

Summary

This study will use the NIH-sponsored Women and Infants Transmission Study (WITS) and the Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) HIV-infected pediatric cohorts to determine how left ventricular (LV) function (particularly fractional shortening and contractility) and structure (particularly wall thickness and mass) are affected by cumulative intensity of exposure to highly active anti-retroviral therapy (HAART).

Conditions

  • HIV Infections

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Clinical Trials & Surveys Corp (C-TASC)

    collaborator INDUSTRY

  • Baylor College of Medicine

    collaborator OTHER

  • University of Illinois at Chicago

    collaborator OTHER

  • Columbia University

    collaborator OTHER

  • Boston Medical Center

    collaborator OTHER

  • Boston Children's Hospital

    collaborator OTHER

  • University of Puerto Rico

    collaborator OTHER

  • State University of New York

    collaborator OTHER

  • University of Miami

    lead OTHER

Principal Investigators

  • Steven E. Lipshultz, MD · University of Miami

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2006-06-30
Completion
2006-06-30

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00260806 on ClinicalTrials.gov